| High-dose rifapentine with moxifloxacin for pulmonary tuberculosis A Jindani, TS Harrison, AJ Nunn, PPJ Phillips, GJ Churchyard, ... New England Journal of Medicine 371 (17), 1599-1608, 2014 | 494 | 2014 |
| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 377 | 2017 |
| Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa P Mee, KL Fielding, S Charalambous, GJ Churchyard, AD Grant Aids 22 (15), 1971-1977, 2008 | 290 | 2008 |
| Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners EL Corbett, S Charalambous, VM Moloi, K Fielding, AD Grant, C Dye, ... American journal of respiratory and critical care medicine 170 (6), 673-679, 2004 | 268 | 2004 |
| " That is why I stopped the ART": Patients'& providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme M Dahab, S Charalambous, R Hamilton, K Fielding, K Kielmann, ... BMC public health 8, 1-6, 2008 | 224 | 2008 |
| Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B CJ Hoffmann, S Charalambous, CL Thio, DJ Martin, L Pemba, KL Fielding, ... Aids 21 (10), 1301-1308, 2007 | 209 | 2007 |
| Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study AD Grant, S Charalambous, KL Fielding, JH Day, EL Corbett, ... Jama 293 (22), 2719-2725, 2005 | 196 | 2005 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 193 | 2016 |
| Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program CJ Hoffmann, S Charalambous, DJ Martin, C Innes, GJ Churchyard, ... Clinical Infectious Diseases 47 (11), 1479-1485, 2008 | 173 | 2008 |
| Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy DA Babb, L Pemba, P Seatlanyane, S Charalambous, GJ Churchyard, ... Psychology, health & medicine 12 (3), 314-320, 2007 | 165 | 2007 |
| HIV and tuberculosis in prisons in sub-Saharan Africa L Telisinghe, S Charalambous, SM Topp, ME Herce, CJ Hoffmann, ... The Lancet 388 (10050), 1215-1227, 2016 | 159 | 2016 |
| Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa Z El-Khatib, AM Ekstrom, J Ledwaba, L Mohapi, F Laher, A Karstaedt, ... Aids 24 (11), 1679-1687, 2010 | 152 | 2010 |
| Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? GJ Churchyard, K Fielding, S Charalambous, JH Day, EL Corbett, ... Aids 17 (14), 2063-2070, 2003 | 152 | 2003 |
| Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? GJ Churchyard, K Fielding, S Charalambous, JH Day, EL Corbett, ... Aids 17 (14), 2063-2070, 2003 | 152 | 2003 |
| Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy CJ Hoffmann, S Charalambous, J Sim, J Ledwaba, G Schwikkard, ... Clinical infectious diseases 49 (12), 1928-1935, 2009 | 139 | 2009 |
| Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy CJ Hoffmann, S Charalambous, J Sim, J Ledwaba, G Schwikkard, ... Clinical infectious diseases 49 (12), 1928-1935, 2009 | 139 | 2009 |
| The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions K Dheda, T Perumal, H Moultrie, R Perumal, A Esmail, AJ Scott, ... The Lancet Respiratory Medicine 10 (6), 603-622, 2022 | 137 | 2022 |
| Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa JH Day, S Charalambous, KL Fielding, RJ Hayes, GJ Churchyard, ... The international journal of tuberculosis and lung disease 10 (5), 523-529, 2006 | 131 | 2006 |
| Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study R Lester, R Hamilton, S Charalambous, T Dwadwa, C Chandler, ... Aids 24, S45-S48, 2010 | 128 | 2010 |
| Contribution of reinfection to recurrent tuberculosis in South African gold miners S Charalambous, AD Grant, V Moloi, R Warren, JH Day, P Van Helden, ... The international journal of tuberculosis and lung disease 12 (8), 942-948, 2008 | 121 | 2008 |
